EN
HI
Summary
As of 4 Nov, 2026, Concord Biotech stock price is ₹655.5. During the trading session, the stock has moved between an intraday low of ₹594.60 and an intraday high of ₹662.00. Over the last 52 weeks, Concord Biotech has traded between ₹594.60 and ₹1615.00.
The stock has recorded a trading volume of 3,55,637 shares,. Its Average Traded Price (ATP) is ₹634.95, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 10 @ ₹655.50.
Concord Biotech has an upper circuit limit of ₹736.80 and a lower circuit limit of ₹491.20. The total value traded stands at ₹22.58 CR, and the delivery percentage for the day is 26.92%.
The stock is currently traded with a market lot size of 1. Concord Biotech also offers a dividend yield of 0.61%.
Concord Biotech Share Price Chart
Concord Biotech Share Key Metrics
Volume
3.56 L
Market Cap
13715.18 CR
LTQ@LTP
10@655.50
ATP
634.95
Var Margin
21.19 %
Circuit Range
491.2-736.8
Delivery %
26.92 %
Value
22.58 CR
ASM/GSM
No
Market Lot
1
Concord Biotech Fundamentals
P/E Ratio
45.55
P/B Ratio
6.2
Div. Yield
0.61
Sector P/E
39.49
Sector P/B
3.29
Sec. Div. Yield
0.54
Concord Biotech Resistance and Support
Pivot 1214.3
Resistance
First Resistance
1261.6
Second Resistance
1295.3
Third Resistance
1342.6
Support
First Support
1180.6
Second Support
1133.3
Third Support
1099.6
Concord Biotech Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Nov 04 2026 | 608 | 655.5 | 6.77% | 662 | 594.6 |
| Tue Nov 03 2026 | 586.5 | 613.95 | 5.54% | 624 | 583.5 |
| Mon Nov 02 2026 | 603.84 | 581.75 | -6.59% | 605 | 578 |
Concord Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-27 | Quarterly Results |
| 2026-09-23 | Bonus issue |
| 2026-07-31 | Quarterly Results |
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Concord Biotech News
Concord Biotech Ltd - 543960 - Intimation Of Record Date For Issuance Of Bonus Equity Shares - November 04, 2026
Concord Biotech has fixed November 4, 2026, as the record date to determine eligibility for its 1:1 bonus share issue. The deemed date of allotment for the new shares is scheduled for November 5, 2026.
Oct 27 2026 19:27:32
Concord Biotech Ltd - 543960 - Board Meeting Outcome for Meeting Held Today I.E. Tuesday, October 27, 2026 - Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations') As Amended From Time To Time.
Concord Biotech reported Q2 FY27 cons. revenue of ₹309.07 crore (up 25% YoY) and net profit of ₹69.57 crore (up 10% YoY). The board fixed November 4, 2026, as the record date for the previously announced 1:1 bonus issue. Additionally, key board committees were reconstituted.
Oct 27 2026 19:03:50
Read More
Concord Biotech Management
| Name | Position |
|---|---|
| Sudhir Vaid | Chairman & Managing Director |
| Ankur Vaid | Joint Managing Director & CEO |
Concord Biotech Similar Stocks
Marksans Pharma Ltd.
301.65
-13.65 (4.33%)
CORONA Remedies Ltd.
2405.80
134.20 (5.91%)
Rainbow Children's Medicare Ltd.
1279.60
33.20 (2.66%)
Alivus Life Sciences Ltd.
1520.70
39.40 (2.66%)
Sudeep Pharma Ltd.
1116.70
17.30 (1.57%)
Metropolis Healthcare Ltd.
581.25
12.55 (2.21%)
Akums Drugs & Pharmaceuticals Ltd.
751.50
-9.65 (1.27%)
Sanofi Consumer Healthcare India Ltd.
3472.60
-23.30 (0.67%)
Viyash Scientific Ltd.
228.46
9.01 (4.11%)
Park Medi World Ltd.
230.45
6.81 (3.05%)
Concord Biotech FAQs
The Buying Price of Concord Biotech share is 655.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Concord Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Concord Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Concord Biotech shares is 45.55. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Concord Biotech shares is 6.2. Useful to assess the stock's value relative to its book value.
To assess Concord Biotech’s valuation compare Sector P/E, P/B which are 39.49 & 3.29 with sector averages, along with growth rates and financial metrics.
The Market Cap of Concord Biotech is 13715.18 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Concord Biotech share price is 1615.00 & 594.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Concord Biotech belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in CONCORDBIO
Or Download Choice FinX App
Invest in CONCORDBIO
